logo

Natco Pharma Ltd. Financials

10:39 Jun 19

Natco Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
876.60
-1.60 (-0.18%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Natco Pharma Ltd. Financials

Natco Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
876.60
-1.60 (-0.18%)
10:39 Jun 19
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

57/100
Affordable Valuation

Technical

37/100
Technically Neutral

Strength

14

Weakness

3

Opportunity

0

Threats

1

24.78 %

ROE %

21.84 %

ROA %

105.26

EPS

424.97

BVPS

42.56 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
2052.1 1944.8 2707.1 3998.8 4429.5
Operating Expenses +
1445.9 1681.3 1771.5 2247.4 2233.5
Raw Material
559.5 577.7 651 673.9 702.3
Increase Decrease in Cost
-48.1 -16.8 -23.7 42.7 -12.5
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
414.9 444.8 486.7 525 594.5
Miscellaneous Expenses
892.8 792.6 1008.9 1308.6 1281.4
Operating Profit
606.2 263.5 935.6 1751.4 2196
Other Income
103.6 99 104.6 128.1 354.5
Depreciation
116.9 142.6 163.8 186.8 235.2
Interest
13.3 17.7 14.5 19.2 23.9
Profit before tax and exceptio..
579.6 202.2 861.9 1673.5 2291.4
Exceptional Items
0 0 0 0 0
PBT
579.6 202.2 861.9 1673.5 2291.4
Provision for Taxation
137.2 32.2 146.6 285.2 408
Net Profit
442.4 170 715.3 1388.3 1883.4
NET Profit after MI
440.9 170 715.3 1388.3 1885.4
EPS
24.16 9.32 39.18 77.34 105.26
Operating Profit Margin (%)
29.54 13.55 34.56 43.8 49.58
Net Profit Margin (%)
21.49 8.74 26.42 34.72 42.56

Natco Pharma Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 49.60 49.60 49.60 49.70 49.70
FII 17.50 17.90 17.50 17.40 16.10
MF 1.80 1.90 2.40 2.70 4.10
Others 3.80 3.70 4.40 5.20 5.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: